share_log

Akero Therapeutics | 8-K: Akero Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

SEC ·  Feb 29 20:18
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.